HomeDMAAU • NASDAQ
Drugs Made In America Acquisition Units
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 279.88K | — |
Net income | -279.88K | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.35K | — |
Total assets | 550.82K | — |
Total liabilities | 795.67K | — |
Total equity | -244.85K | — |
Shares outstanding | 33.52M | — |
Price to book | -343.33 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -279.88K | — |
Cash from operations | -123.15K | — |
Cash from investing | — | — |
Cash from financing | 123.37K | — |
Net change in cash | 221.00 | — |
Free cash flow | — | — |
Previous close
$10.30
Year range
$10.00 - $10.50
Market cap
339.03M USD
Avg Volume
15.04K
About
Founded
2024
Website